HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.

AbstractOBJECTIVE:
Although it has been reported that oral administration of tetrahydrobiopterin (BH4) prevents endothelial dysfunction and vascular oxidative stress in various rat models, the effect of treatment with BH4 on atherogenesis remains unclear.
METHODS AND RESULTS:
In this study, we investigated whether oral BH4 treatment might slow the progression of atherosclerosis using hypercholesterolemic apolipoprotein E-knockout mice. We report that ingesting BH4 in drinking water is sufficient to inhibit atherogenesis in mice. Furthermore, we report that BH4 treatment improves endothelial dysfunction and attenuates increased mRNA expression of NADPH oxidase components, as well as a number of inflammatory factors, such as LOX-1 and MCP-1, in the aortas of apolipoprotein E- knockout mice.
CONCLUSION:
Strategies such as oral administration of BH4 to ensure continuous BH4 availability may be effective in restoring nitric oxide-mediated endothelial function and limiting vascular disease and the progression of atherosclerosis.
AuthorsYoshiyuki Hattori, Sachiko Hattori, Xi Wang, Hiroko Satoh, Nobuo Nakanishi, Kikuo Kasai
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 27 Issue 4 Pg. 865-70 (Apr 2007) ISSN: 1524-4636 [Electronic] United States
PMID17272747 (Publication Type: Journal Article)
Chemical References
  • Apolipoproteins E
  • Inflammation Mediators
  • RNA, Messenger
  • Superoxides
  • Biopterin
  • sapropterin
Topics
  • Administration, Oral
  • Animals
  • Aorta (metabolism)
  • Apolipoproteins E (deficiency)
  • Atherosclerosis (etiology, metabolism, pathology, physiopathology)
  • Biopterin (administration & dosage, analogs & derivatives, pharmacokinetics, pharmacology)
  • Disease Progression
  • Endothelium, Vascular (drug effects, physiopathology)
  • Hypercholesterolemia (complications)
  • Immunohistochemistry
  • Inflammation Mediators (antagonists & inhibitors)
  • Mice
  • Mice, Knockout
  • RNA, Messenger (antagonists & inhibitors)
  • Superoxides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: